Chain Drug Consortium, The Premier Value Alliance announce merger

BOCA RATON, Fla. and Park City, Utah — Chain Drug Consortium has merged with its Premier Value Alliance subsidiary to form a new combined organization, which will operate as Chain Drug Consortium, LCC.  



The new organization will continue to provide its members with a broad portfolio of pharmacy industry programs and benefits, such as the Premier Value brand program.



Edward Frisch, founding president and CEO of CDC and PVA, has resigned and will remain a consultant to the new company.



 “I am very proud to have developed our unique business model, driving $1 billion in member retail programs and $100 million in member savings, since 2000. I am very confident that our board of directors and management will continue on this path,” Frisch stated.



Ed McGinley, CDC VP of pharmacy, resigned in February to pursue new consulting ventures.



Lou Helfrich, CDC VP of purchasing, will continue to manage CDC’s Premier Value brand program, based in Pittsburg, Pa.



George Bartell, chairman and CEO of Bartell Drugs, will continue as CDC chairman.  



"Eddie Frisch and Ed McGinley have been valuable assets to both organizations, and their contributions through the years are greatly appreciated,” Bartell stated.



Steve Rule, president and CEO of The Rule Group is the CDC’s new president, and he will be opening a new office in Park City, Utah.  The Boca Raton, Fla., office will be closed at the end of May.